Thanks to the American Academy of Neurology (AAN), obtaining the latest information on neurological conditions is a cinch.
Thanks to collaborative efforts of the University of Michigan Consortium for Stem Cell Therapies and molecular research scientists at Michigan-based Genesis Genetics, scientists are one step closer to understanding Charcot-Marie-Tooth disease.
Learn more from orthopedic surgeon Glenn Pfeffer, MD about surgery and CMT patients.
A recent article in More magazine featured the story of Hereditary Neuropathy Foundation president Allison Moore and her experiences living with Charcot-Marie-Tooth.
HNF is committed to pursuing treatment and a cure for Charcot-Marie-Tooth disease, and we cannot fulfill this mission without your help.
We are currently funding two very important research projects, one for CMT type 1 and the other for CMT type 2A.
This CMT patient has worked with thousands of CMT families and draws her knowledge from past and present experiences.
0 Comments